Page last updated: 2024-12-07

5-(tetradecyloxy)-2-furancarboxylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-(tetradecyloxy)-2-furancarboxylic acid: has antineoplastic activity; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

5-(tetradecyloxy)-2-furoic acid : A member of the class of furans that is 2-furoic acid in which the hydrogen at position 5 is replaced by a tetradecyloxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID115175
CHEMBL ID1562779
CHEBI ID77936
SCHEMBL ID543676
MeSH IDM0062725

Synonyms (56)

Synonym
54857-86-2
rmi-14514
ac-8632 ,
TOFA ,
rmi 14514
mdl 14514
2-furancarboxylic acid, 5-(tetradecyloxy)-
5-tetradecyloxy-2-furonic acid
brn 0539681
5-(tetradecyloxy)-2-furancarboxylic acid
NCGC00165908-01
5-(tetradecyloxy)-2-furoic acid
5-tetradecoxyfuran-2-carboxylic acid
NCGC00165908-02
rmi-14,514
chebi:77936 ,
rmi 14,514
CHEMBL1562779
olumacostat
bi12fry055 ,
unii-bi12fry055
AKOS015994758
S6690
5-(tetradecyloxy)furan-2-carboxylic acid
gtpl5280
5-(tetradecyloxy)furoic acid
CZRCFAOMWRAFIC-UHFFFAOYSA-N
5-tetradecyloxy-2-furoic acid
SCHEMBL543676
tofa, rmi 14514
SS-4313
HMS3649D14
DTXSID60203338
EX-A1198
tofa (5-(tetradecyloxy)-2-furoic acid)
tofa, >=98% (hplc)
5-tetradecyloxy-furan-2-carboxylic acid
CS-6290
HY-101068
FT-0769937
BCP20578
tofa - cas 54857-86-2
Q27089005
SR-01000946703-1
rmi14514
sr-01000946703
mdl14514
SB17381
HMS3874J13
kd-023
AMY39894
HMS3743I11
rmi14514;mdl14514
compound summary
SRCT-03743
AC-35468

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"The hypolipidemic drug RMI 14,514 (5-tetradecyloxy-2-furoic acid) has an oral LD50 of over 5000 mg/kg in rats."( Toxicity and teratogenicity studies with the hypolipidemic drug RMI 14,514 in rats.
Blohm, TR; Gibson, JP; Hook, RH; Kariya, T; Larson, EJ; Yarrington, JT,
)
0.13
" The data suggest that differences in intermediary metabolism render tumor cells susceptible to toxic fluxes in malonyl-CoA, both in vitro and in vivo."( Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts.
Chrest, FJ; Frehywot, GL; Han, WF; Kuhajda, FP; Pinn, ML; Pizer, ES; Thupari, J; Townsend, CA, 2000
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitorAn EC 6.4.1.* (C-C bond-forming ligase) inhibitor that interferes with the action of acetyl-CoA carboxylase (EC 6.4.1.2).
PPARalpha agonistA PPAR modulator which activates the peroxisome proliferator-activated receptor-alpha.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
apoptosis inducerAny substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
furoic acidA monocarboxylic acid that consists of a furan ring having a single carboxylic acid group on any ring position and derivatives thereof.
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency25.11890.003245.467312,589.2998AID2517
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency29.88160.004023.8416100.0000AID485290; AID489007
Chain A, Ferritin light chainEquus caballus (horse)Potency11.22025.623417.292931.6228AID485281
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency11.22020.354828.065989.1251AID504847
DNA polymerase kappa isoform 1Homo sapiens (human)Potency11.91730.031622.3146100.0000AID588579
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency7.07950.251215.843239.8107AID504327
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (39)

Assay IDTitleYearJournalArticle
AID1190522Reduction in phosphatidylethanolamine content in human LNCAP cells at 10 uM after 72 hrs by nile red staining based fluorescence microscopy2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Denhaminols A-H, dihydro-β-agarofurans from the endemic Australian rainforest plant Denhamia celastroides.
AID1147322Hypolipidemic activity in Wistar rat assessed as reduction in plasma triglyceride level at 314 umol/kg/day administered through diet for 10 days1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1147130Hypolipidemic activity in Wistar rat assessed as reduction in plasma cholesterol level at 154 umol/kg/day administered through diet for 10 days1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1147324Hypolipidemic activity in Wistar rat assessed as reduction in plasma triglyceride level at 583 umol/kg/day administered through diet for 10 days1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1147441Increase in liver weight in Wistar rat at 583 umol/kg/day administered through diet for 10 days1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1404385Induction of cholesterol metabolism deregulation in human LNCAP cells assessed as reduction in NBD-cholesterol uptake at 10 uM after 48 hrs by DAPI/Alexa fluor 633 phalloidin staining based high-content imaging analysis2018Journal of natural products, 04-27, Volume: 81, Issue:4
Identification of Gibberellic Acid Derivatives That Deregulate Cholesterol Metabolism in Prostate Cancer Cells.
AID1190519Reduction in triglyceride content in human LNCAP cells at 10 uM after 72 hrs by nile red staining based fluorescence microscopy2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Denhaminols A-H, dihydro-β-agarofurans from the endemic Australian rainforest plant Denhamia celastroides.
AID1147133Hypolipidemic activity in Wistar rat assessed as reduction in plasma cholesterol level at 583 umol/kg/day administered through diet for 10 days1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1147540Inhibition of fatty acid synthesis in Wistar rat liver assessed as drug incorporation into phospholipid administered for 2 weeks by gas chromatography1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1190523Reduction in phosphatidylserine content in human LNCAP cells at 10 uM after 72 hrs by nile red staining based fluorescence microscopy2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Denhaminols A-H, dihydro-β-agarofurans from the endemic Australian rainforest plant Denhamia celastroides.
AID1147542Hypolipidemic activity in rhesus monkey assessed as reduction in plasma cholesterol level at 308 umol/kg/day administered for 28 days1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1147439Increase in liver weight in Wistar rat at 314 umol/kg/day administered through diet for 10 days1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1228106Antilipogenic activity in human LNCAP cells assessed as reduction of cellular phospholipid level at 10 uM after 48 hrs by nile red staining-based fluorescence microscopic analysis relative to control2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Design and Synthesis of a Screening Library Using the Natural Product Scaffold 3-Chloro-4-hydroxyphenylacetic Acid.
AID1147525Increase in cholesterol level in Wistar rat liver at 583 umol/kg/day administered through diet for 10 days1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1147530Inhibition of cholesterol biosynthesis in Ad Lib fed Wistar rat liver assessed as sodium [1-14C]acetate incorporation at 154 mg/kg/day administered through diet for 7 days measured 1 hr after labeled acetate challenge by liquid scintillation spectrometry 1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1147532Inhibition of cholesterol biosynthesis in meal fed Wistar rat liver assessed as sodium [1-14C]acetate incorporation at 95 mg/kg/day administered through diet for 7 days measured 1 hr after labeled acetate challenge by liquid scintillation spectrometry (Rv1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1147323Hypolipidemic activity in Wistar rat assessed as reduction in plasma triglyceride level at 410 umol/kg/day administered through diet for 4 days1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1190518Reduction in sterol content in human LNCAP cells at 10 uM after 72 hrs by nile red staining based fluorescence microscopy2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Denhaminols A-H, dihydro-β-agarofurans from the endemic Australian rainforest plant Denhamia celastroides.
AID1147541Hypolipidemic activity in rhesus monkey assessed as reduction in plasma cholesterol level at 92 umol/kg/day administered for 28 days1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1228102Antilipogenic activity in human PC3 cells assessed as reduction of cellular neutral lipid level at 10 uM after 48 hrs by nile red staining-based fluorescence microscopic analysis relative to control2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Design and Synthesis of a Screening Library Using the Natural Product Scaffold 3-Chloro-4-hydroxyphenylacetic Acid.
AID1228107Antilipogenic activity in human LNCAP cells assessed as reduction of cellular neutral lipid level at 10 uM after 48 hrs by nile red staining-based fluorescence microscopic analysis relative to control2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Design and Synthesis of a Screening Library Using the Natural Product Scaffold 3-Chloro-4-hydroxyphenylacetic Acid.
AID1147440Increase in liver weight in Wistar rat at 410 umol/kg/day administered through diet for 4 days1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1147524Increase in cholesterol level in Wistar rat liver at 410 umol/kg/day administered through diet for 4 days1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1147522Increase in cholesterol level in Wistar rat liver at 154 umol/kg/day administered through diet for 10 days1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1147321Hypolipidemic activity in Wistar rat assessed as reduction in plasma triglyceride level at 154 umol/kg/day administered through diet for 10 days1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1147523Increase in cholesterol level in Wistar rat liver at 314 umol/kg/day administered through diet for 10 days1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1190521Reduction in phosphatidylcholine content in human LNCAP cells at 10 uM after 72 hrs by nile red staining based fluorescence microscopy2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Denhaminols A-H, dihydro-β-agarofurans from the endemic Australian rainforest plant Denhamia celastroides.
AID1147534Inhibition of fatty acid biosynthesis in Ad Lib fed Wistar rat liver assessed as sodium [1-14C]acetate incorporation at 154 mg/kg/day administered through diet for 7 days measured 1 hr after labeled acetate challenge by liquid scintillation spectrometry (1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID697040Inhibition of acetyl coA carboxylase in human MCF7 cells2011Journal of medicinal chemistry, Aug-25, Volume: 54, Issue:16
The lipogenesis pathway as a cancer target.
AID1147538Inhibition of cholesterol synthesis in Wistar rat liver assessed as drug incorporation into triglycerides administered for 2 weeks by gas chromatography1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1147539Inhibition of cholesterol synthesis in Wistar rat liver assessed as drug incorporation into cholesterol ester administered for 2 weeks by gas chromatography1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1147131Hypolipidemic activity in Wistar rat assessed as reduction in plasma cholesterol level at 314 umol/kg/day administered through diet for 10 days1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1147438Increase in liver weight in Wistar rat at 154 umol/kg/day administered through diet for 10 days1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1147132Hypolipidemic activity in Wistar rat assessed as reduction in plasma cholesterol level at 410 umol/kg/day administered through diet for 4 days1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1147536Inhibition of fatty acid biosynthesis in meal fed Wistar rat liver assessed as sodium [1-14C]acetate incorporation at 95 mg/kg/day administered through diet for 7 days measured 1 hr after labeled acetate challenge by liquid scintillation spectrometry (Rvb1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.
AID1228108Antilipogenic activity in human PC3 cells assessed as reduction of cellular phospholipid level at 10 uM after 48 hrs by nile red staining-based fluorescence microscopic analysis relative to control2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Design and Synthesis of a Screening Library Using the Natural Product Scaffold 3-Chloro-4-hydroxyphenylacetic Acid.
AID1190520Reduction in fatty acid content in human LNCAP cells at 10 uM after 72 hrs by nile red staining based fluorescence microscopy2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Denhaminols A-H, dihydro-β-agarofurans from the endemic Australian rainforest plant Denhamia celastroides.
AID1345212Human Acetyl-CoA carboxylase 2 (Carboxylases)2003Cancer research, Nov-01, Volume: 63, Issue:21
Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.
AID1345249Human Acetyl-CoA carboxylase 1 (Carboxylases)2003Cancer research, Nov-01, Volume: 63, Issue:21
Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (50)

TimeframeStudies, This Drug (%)All Drugs %
pre-199019 (38.00)18.7374
1990's5 (10.00)18.2507
2000's10 (20.00)29.6817
2010's14 (28.00)24.3611
2020's2 (4.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.71 (24.57)
Research Supply Index3.95 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.71)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other51 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]